Cultivate at Scale, a facility designed to support the scaling of cellular agriculture, has entered into a collaboration with ...

After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...

Leipzig will welcome leading voices from biotech, pharma, academia, and investment to the inaugural European Biopharma ...

XP 8121 is a combination drug meant to better control hypothyroidism, in part by moving its common therapy, levothyroxine, ...

The interim data, with a cutoff date of April 11, 2025, showed an impressive 70% CR rate. Prior to NXC-201 treatment, the ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

Cold chain monitoring solutions have become indispensable to the biopharma business for managing complicated supply chains.

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today ...

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and ...

French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for $9.5 billion, sending shares of the ...

France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for over $9 billion to boost its position in ...